Your browser doesn't support javascript.
loading
Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study.
Kim, Haein; Jang, Young Rock; Lee, Ji Yeon; Ko, Jae-Hoon; Lee, Jee Young; Cho, Seongcheol; Lee, Yong Dae; Song, Junghoon; Hyun, Miri; Kim, Hyun Ah; Hwang, Soyoon; Ryou, Sangmi; Na, Yoo Jin; Lee, Joo-Yeon; Lee, Changhee; Lee, Nan Young; Shin, Seunghwan; Kwon, Ki Tae; Kim, Jin Yong; Peck, Kyong Ran.
Affiliation
  • Kim H; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Jang YR; Division of Infectious Diseases, Department of Internal Medicine, Incheon Medical Center, Incheon, Republic of Korea.
  • Lee JY; Division of Infectious Diseases, Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
  • Ko JH; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Lee JY; Department of Internal Medicine, Seoul Red Cross Hospital, Seoul, Republic of Korea.
  • Cho S; Department of Internal Medicine, Seoul Red Cross Hospital, Seoul, Republic of Korea.
  • Lee YD; Department of Internal Medicine, Seoul Red Cross Hospital, Seoul, Republic of Korea.
  • Song J; Department of Internal Medicine, Seoul Red Cross Hospital, Seoul, Republic of Korea.
  • Hyun M; Division of Infectious Diseases, Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
  • Kim HA; Division of Infectious Diseases, Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
  • Hwang S; Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Ryou S; Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
  • Na YJ; Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
  • Lee JY; Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
  • Lee C; College of Veterinary Medicine and Virus Vaccine Research Center, Gyeongsang National University, Jinju, Republic of Korea.
  • Lee NY; Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Shin S; Department of Internal Medicine, Seoul Red Cross Hospital, Seoul, Republic of Korea.
  • Kwon KT; Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Kim JY; Division of Infectious Diseases, Department of Internal Medicine, Incheon Medical Center, Incheon, Republic of Korea.
  • Peck KR; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Front Cell Infect Microbiol ; 13: 1192512, 2023.
Article in En | MEDLINE | ID: mdl-37256107
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Cell Infect Microbiol Year: 2023 Document type: Article Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Cell Infect Microbiol Year: 2023 Document type: Article Country of publication: Suiza